March 17, 2020 / 8:53 PM / 22 days ago

BRIEF-Cue Biopharma Reports Qtrly Loss Per Share Of $0.37

March 17 (Reuters) - Cue Biopharma Inc:

* CUE BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

* QTRLY COLLABORATION REVENUE OF ABOUT $1.0 MILLION VERSUS $0.3 MILLION

* QTRLY LOSS PER SHARE $0.37

* Q4 EARNINGS PER SHARE VIEW $-0.45, REVENUE VIEW $873000.00 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below